Last reviewed · How we verify
Non-infective diarrhea
Approved treatments
- Mytesi · Napo Pharms Inc
Mytesi works by blocking the action of a specific protein called anoctamin-1, which helps regulate the movement of water and electrolytes in the intestines.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Non-infective diarrhea patent landscape — cliff calendar, originator estates, attackable patents
- Non-infective diarrhea treatment landscape brief
- Non-infective diarrhea treatment updates RSS
Frequently asked questions about Non-infective diarrhea
What drugs treat Non-infective diarrhea?
Tracked treatments include Mytesi.
What is the treatment for Non-infective diarrhea?
Standard treatment for Non-infective diarrhea includes Mytesi. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Non-infective diarrhea patent cliff · Non-infective diarrhea CI report
- Treatment: Mytesi · Napo Pharms Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing